Nucana Plc current report, Q2 FY2021

Nucana Plc Form 6-K Summary

Business Context and Reporting Period

Nucana Plc, a foreign private issuer based in Edinburgh, United Kingdom, filed this Form 6-K on August 19, 2021. The filing reports on "Other Events" and incorporates by reference the Company's unaudited condensed consolidated financial statements and Management's Discussion and Analysis for the three and six months ended June 30, 2021.

Key Financial Metrics

The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached exhibits (Exhibit 99.1 and 99.2) which are incorporated by reference but not detailed in the body of this Form 6-K.

Material Changes and Corporate Actions

  • Equity Offering Program Update: On August 19, 2021, the Company entered into a new Open Market Sale Agreement with Jefferies LLC to sell American Depositary Shares (ADSs) with an aggregate offering price of up to $100.0 million via an "at-the-market" program.
  • Termination of Prior Agreement: Concurrently, the Company terminated its prior Sales Agreement with Cowen and Company, LLC, effective August 19, 2021. No termination penalties were incurred.
  • Proceeds from Prior Program: Under the terminated agreement with Cowen, the Company issued and sold 774,511 ADSs (representing 774,511 ordinary shares), generating gross proceeds of approximately $4.7 million (£3.7 million).

Guidance, Outlook, and Risks

Specific guidance, outlook, or detailed risk factors are not provided in the text of this Form 6-K. The filing references Exhibit 99.3 for Risk Factors and Exhibit 99.2 for Management's Discussion and Analysis, which contain the relevant commentary and forward-looking statements.

Investor Verification Checklist

  • Review Exhibit 99.1 for specific Q2 2021 revenue, net loss, and cash position figures.
  • Verify the terms of the new $100 million ATM program with Jefferies LLC in the upcoming Form F-3 Registration Statement.
  • Confirm the impact of the $4.7 million raised under the prior Cowen agreement on the Company's current liquidity.
  • Examine Exhibit 99.3 for updated risk factors relevant to the Company's operations and capital structure.